Genetics & Genomics Archive — Page 2 of 15

Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)
February 4, 2026

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

(iStock)
January 16, 2026

Study finds so-called super agers tend to have at least two key genetic advantages

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.

(iStock image)
January 7, 2026

Study identifies potential target for blood cancer treatment, prevention

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.

Annet Kirabo, DVM, MSc, PhD
December 23, 2025

Annet Kirabo named ‘Top Scholar’ in hypertension

The distinction places her among the top 0.05% of scholars worldwide in her specialty, hypertension.

December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

November 17, 2025

New grant supports epilepsy study in Africa’s Sahel region

In this area, treatment gaps affect up to 96% of patients, leaving millions without care. The project is funded by the National Institute of Neurological Disorders and Stroke of the NIH.